129 related articles for article (PubMed ID: 17115112)
1. Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.
Ciatto S; Houssami N; Ambrogetti D; Bonardi R; Collini G; Del Turco MR
Breast Cancer Res Treat; 2007 Sep; 105(1):37-43. PubMed ID: 17115112
[TBL] [Abstract][Full Text] [Related]
2. Rapid Access to Contrast-Enhanced spectral mammogRaphy in women recalled from breast cancer screening: the RACER trial study design.
Neeter LMFH; Houben IPL; Nelemans PJ; Van Nijnatten TJA; Pijnappel RM; Frotscher C; Osinga-de Jong M; Sanders F; Van Dalen T; Raat HPJ; Essers BAB; Wildberger JE; Smidt ML; Lobbes MBI
Trials; 2019 Dec; 20(1):759. PubMed ID: 31870414
[TBL] [Abstract][Full Text] [Related]
3. Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI.
Dittus K; Geller B; Weaver DL; Kerlikowske K; Zhu W; Hubbard R; Braithwaite D; O'Meara ES; Miglioretti DL;
J Gen Intern Med; 2013 Nov; 28(11):1454-62. PubMed ID: 23760741
[TBL] [Abstract][Full Text] [Related]
4. False negative breast cancers on imaging and associated risk factors: a single institution six-year analysis.
Franklin J; Hayes J; Knippa E; Dogan B
Breast Cancer Res Treat; 2024 Jun; 205(3):507-520. PubMed ID: 38483757
[TBL] [Abstract][Full Text] [Related]
5. Radiological features of screening-detected and interval breast cancers and subsequent survival in Eastern Finnish women.
Nykänen A; Sudah M; Masarwah A; Vanninen R; Okuma H
Sci Rep; 2024 May; 14(1):10001. PubMed ID: 38693256
[TBL] [Abstract][Full Text] [Related]
6. Errors in Mammography Cannot be Solved Through Technology Alone.
Ekpo EU; Alakhras M; Brennan P
Asian Pac J Cancer Prev; 2018 Feb; 19(2):291-301. PubMed ID: 29479948
[TBL] [Abstract][Full Text] [Related]
7. Survival among women diagnosed with screen-detected or interval breast cancer classified as true, minimal signs, or missed through an informed radiological review.
Tsuruda KM; Hovda T; Bhargava S; Veierød MB; Hofvind S
Eur Radiol; 2021 May; 31(5):2677-2686. PubMed ID: 33180162
[TBL] [Abstract][Full Text] [Related]
8. Navigating Latinas with breast screen abnormalities to diagnosis: the Six Cities Study.
Ramirez AG; Pérez-Stable EJ; Penedo FJ; Talavera GA; Carrillo JE; Fernandez ME; Holden AE; Munoz E; San Miguel S; Gallion K
Cancer; 2013 Apr; 119(7):1298-305. PubMed ID: 23233265
[TBL] [Abstract][Full Text] [Related]
9. A Prospective Analysis of Screen-Detected Cancers Recalled and Not Recalled by Artificial Intelligence.
Smith SJ; Bradley SA; Walker-Stabeler K; Siafakas M
J Breast Imaging; 2024 May; ():. PubMed ID: 38801724
[TBL] [Abstract][Full Text] [Related]
10. Introduction of organised mammography screening in Tyrol: results following first year of complete rollout.
Oberaigner W; Daniaux M; Geiger-Gritsch S; Knapp R; Siebert U; Buchberger W
BMC Public Health; 2011 Aug; 11():673. PubMed ID: 21878122
[TBL] [Abstract][Full Text] [Related]
11. Introduction of organised mammography screening in Tyrol: results of a one-year pilot phase.
Oberaigner W; Buchberger W; Frede T; Daniaux M; Knapp R; Marth C; Siebert U
BMC Public Health; 2011 Feb; 11():91. PubMed ID: 21306614
[TBL] [Abstract][Full Text] [Related]
12. Comparison of false negative rates among breast cancer screening modalities with or without mammography: Miyagi trial.
Ohuchi N; Yoshida K; Kimura M; Ouchi A; Shiiba K; Ohnuki K; Fukao A; Abe R; Matsuno S; Mori S
Jpn J Cancer Res; 1995 May; 86(5):501-6. PubMed ID: 7790323
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic invasiveness and psychosocial consequences of false-positive mammography.
Heleno B; Siersma VD; Brodersen J
Ann Fam Med; 2015; 13(3):242-9. PubMed ID: 25964402
[TBL] [Abstract][Full Text] [Related]
14. If you don't find it often, you often don't find it: why some cancers are missed in breast cancer screening.
Evans KK; Birdwell RL; Wolfe JM
PLoS One; 2013; 8(5):e64366. PubMed ID: 23737980
[TBL] [Abstract][Full Text] [Related]
15. Effect of Breast Screening Regimen on Breast Cancer Outcomes: A Modeling Study.
Yaffe MJ; Mainprize JG
Curr Oncol; 2023 Oct; 30(11):9475-9483. PubMed ID: 37999106
[TBL] [Abstract][Full Text] [Related]
16. Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces.
Olivotto IA; Bancej C; Goel V; Snider J; McAuley RG; Irvine B; Kan L; Mirsky D; Sabine MJ; McGilly R; Caines JS
CMAJ; 2001 Aug; 165(3):277-83. PubMed ID: 11517642
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the interval cancer rate and its determinants on the Girona Health Region's early breast cancer detection program.
Renart-Vicens G; Puig-Vives M; Albanell J; Castañer F; Ferrer J; Carreras M; Tarradas J; Sala M; Marcos-Gragera R
BMC Cancer; 2014 Aug; 14():558. PubMed ID: 25085350
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of a program of early breast cancer detection in a rural area].
Escribano-Hernández A; Domínguez-Bidagor J; Ferrándiz-Santos J
Aten Primaria; 2000 Mar; 25(5):308-12. PubMed ID: 10853499
[TBL] [Abstract][Full Text] [Related]
19. Examining the impact of COVID-19 disruptions on population-based breast cancer screening in Ireland.
O'Driscoll J; Mooney T; Kearney P; Williams Y; Lynch S; Connors A; Larke A; McNally S; O'Doherty A; Murphy L; Bennett KE; Fitzpatrick P; Mullooly M; Flanagan F
J Med Screen; 2024 Mar; ():9691413241232899. PubMed ID: 38509806
[TBL] [Abstract][Full Text] [Related]
20. Decoding the Prevalent High-Risk Breast Cancers: Demographics, Pathological, Imaging Insights, and Long-Term Outcome.
Alvarenga P; Park JY; Pinto R; Parente D; Lajkosz K; Westergard S; Ghai S; Kim R; Kulkarni S; Au F; Chamadoira J; Freitas V
Can Assoc Radiol J; 2024 May; ():8465371241253254. PubMed ID: 38795027
[No Abstract] [Full Text] [Related]
[Next] [New Search]
